RNS Number : 2969P
Stenprop Limited
07 February 2019
 

 

 

 

 

STENPROP LIMITED

 ("Stenprop" or the "Company")

 

TRANSACTION IN OWN SHARES

 

7 February 2019

 

Further to the announcement published on 20 December 2018 informing shareholders that the Company intended to repurchase shares to mitigate the dilutive effect of the scrip dividend election, shareholders are advised that on 6 February 2019, the Company purchased 260,000 ordinary shares at 111.86 pence per share. These shares will be held as treasury shares.

 

Following the above transaction, the total number of treasury shares held by the Company is 14,477,469 ordinary shares and the total number of shares in issue less shares held in treasury is 279,932,125 ordinary shares. From 6 February 2019, the total number of voting rights in the Company is 279,932,125.

 

 

For further information:

Stenprop Limited                                                                                          44(0)20 3918 6600

Paul Arenson

Patsy Watson

Julian Carey

 

Numis Securities Limited (Financial Adviser)                                          44(0)20 7260 1000

Hugh Jonathan

Vicki Paine  

 

Tavistock (PR Adviser)                                                                                 44(0)20 7920 3150

James Whitmore

James Verstringhe

Kirsty Allan

 

Java Capital Trustees and Sponsors Proprietary Limited                     27 (0)11 722 3050

(JSE sponsor)

            

About Stenprop:

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSUNANRKKAURAR